Treatment of HCC cells with propranolol (a nonselective β-adrenergic receptor antagonist) decreased epinephrine-induced PLAGL2 and vimentin expression (Fig. 3a, b). The gene discussed is VIM; the disease is hepatocellular carcinoma.